Matteo Nardin
Icahn School of Medicine at Mount Sinai
9 Papers
81 Citations
Matteo Nardin is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Percutaneous coronary intervention & Medicine. The author has an hindex of 2, co-authored 9 publications. Previous affiliations of Matteo Nardin include University of Brescia.
Chat about Author
Papers
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
M. Verdoia,Patrizia Pergolini,Roberta Rolla,Matteo Nardin,A. Schaffer,Lucia Barbieri,Paolo Marino,Giorgio Bellomo,H. Suryapranata,G. De Luca +9 more
TL;DR: In patients receiving dual antiplatelet therapy, advanced age is independently associated with a reduced effectiveness of ADP antagonists and a higher rate of HRPR with both clopidogrel and ticagrelor.
64
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
Roxana Mehran,Ruth Owen,Mauro Chiarito,Mauro Chiarito,Usman Baber,Samantha Sartori,Davide Cao,Johny Nicolas,Carlo Andrea Pivato,Carlo Andrea Pivato,Matteo Nardin,Prakash Krishnan,Annapoorna Kini,Samin K. Sharma,Stuart J. Pocock,George Dangas +15 more
TL;DR: In this article, a simple risk score based on readily available variables from patients undergoing PCI can accurately discriminate the risk of contrast-associated acute kidney injury, the occurrence of which is strongly associated with subsequent death.
61
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis.
Anne H. Tavenier,Roxana Mehran,Mauro Chiarito,Davide Cao,Carlo Andrea Pivato,Carlo Andrea Pivato,Johny Nicolas,Frans Beerkens,Matteo Nardin,Samantha Sartori,Usman Baber,Dominick J. Angiolillo,Davide Capodanno,Marco Valgimigli,Renicus S Hermanides,Arnoud W J van 't Hof,Jur ten Berg,Kiyuk Chang,Annapoorna Kini,Samin K. Sharma,George Dangas +20 more
TL;DR: DAPT de-escalation after PCI for ACS, both unguided and guided by genetic or platelet function testing, was associated with lower rates of clinically relevant bleeding and ischemic events as compared to standard DAPT with potent P2Y12 inhibitors based on five open-label RCTs reviewed.
41
Types of myocardial injury and mid-term outcomes in patients with COVID-19.
Annapoorna Kini,Davide Cao,Matteo Nardin,Matteo Nardin,Samantha Sartori,Zhongjie Zhang,Carlo Andrea Pivato,Carlo Andrea Pivato,Mauro Chiarito,Mauro Chiarito,Johny Nicolas,Yuliya Vengrenyuk,Parasuram Krishnamoorthy,Samin K. Sharma,George Dangas,Valentin Fuster,Roxana Mehran +16 more
TL;DR: In this paper, the authors evaluated the acute and chronic patterns of myocardial injury among patients with coronavirus disease-2019 (COVID-19), and their mid-term outcomes.
32
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
Johny Nicolas,Frans Beerkens,Davide Cao,Samantha Sartori,Carlo Andrea Pivato,Hanbo Qiu,Gennaro Giustino,Mauro Chiarito,Mauro Chiarito,Bimmer E. Claessen,Zhongjie Zhang,Matteo Nardin,Victor Razuk,Davis Jones,Anton Camaj,David A. Power,Bryana Banashefski,Joseph Sweeny,Usman Baber,George Dangas,Samin K. Sharma,Annapoorna Kini,Roxana Mehran +22 more
TL;DR: In this article, the authors evaluated the performance of the ARC-HBR criteria among patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) compared to patients with chronic coronary syndrome (CCS).
14